Acadia Healthcare Company, Inc. $ACHC Stock Acquired by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. increased its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 2.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,703,240 shares of the company’s stock after acquiring an additional 98,173 shares during the quarter. Acadia Healthcare makes up about 0.7% of Jefferies Financial Group Inc.’s holdings, making the stock its 9th biggest position. Jefferies Financial Group Inc. owned 3.98% of Acadia Healthcare worth $101,839,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Penn Capital Management Company LLC purchased a new position in Acadia Healthcare during the 3rd quarter worth $15,434,000. Prescott Group Capital Management L.L.C. increased its stake in Acadia Healthcare by 40.0% in the third quarter. Prescott Group Capital Management L.L.C. now owns 70,000 shares of the company’s stock valued at $1,925,000 after purchasing an additional 20,000 shares during the period. Pinnacle Wealth Planning Services Inc. raised its holdings in shares of Acadia Healthcare by 20.7% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 3,209 shares of the company’s stock valued at $88,000 after buying an additional 550 shares during the last quarter. Congress Asset Management Co. raised its holdings in shares of Acadia Healthcare by 20.8% in the third quarter. Congress Asset Management Co. now owns 287,390 shares of the company’s stock valued at $7,903,000 after buying an additional 49,418 shares during the last quarter. Finally, WINTON GROUP Ltd boosted its stake in shares of Acadia Healthcare by 1.4% during the second quarter. WINTON GROUP Ltd now owns 255,451 shares of the company’s stock worth $7,543,000 after buying an additional 3,449 shares during the period.

Acadia Healthcare Stock Up 0.4%

Shares of Acadia Healthcare stock opened at $38.80 on Thursday. The company has a market cap of $3.61 billion, a P/E ratio of -3.11, a PEG ratio of 4.84 and a beta of 0.64. The company has a debt-to-equity ratio of 1.15, a quick ratio of 1.60 and a current ratio of 1.60. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $39.70. The firm has a fifty day moving average of $30.04 and a two-hundred day moving average of $26.50.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, November 4th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.46 by $0.14. The company had revenue of $895.31 million during the quarter, compared to analysts’ expectations of $877.76 million. Acadia Healthcare had a negative net margin of 33.07% and a positive return on equity of 6.53%. The business’s revenue was up 5.1% on a year-over-year basis. During the same quarter last year, the business earned $0.72 EPS. On average, analysts forecast that Acadia Healthcare Company, Inc. will post 1.74 earnings per share for the current year.

Analyst Ratings Changes

ACHC has been the topic of a number of research reports. Cantor Fitzgerald raised their price target on Acadia Healthcare from $30.00 to $39.00 and gave the stock a “neutral” rating in a report on Friday, November 6th. Leerink Partners upped their price objective on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research note on Wednesday, September 23rd. Zacks Research raised Acadia Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Monday. Royal Bank Of Canada increased their price objective on Acadia Healthcare from $31.00 to $41.00 and gave the stock an “outperform” rating in a research report on Friday, November 6th. Finally, Barclays lifted their target price on Acadia Healthcare from $32.00 to $35.00 and gave the company an “equal weight” rating in a research note on Thursday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $32.54.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc. is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care. Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.